FDA Inspection 1068143 — Universal Biopharma Research Institute, Inc.
The FDA completed an inspection of Universal Biopharma Research Institute, Inc. on Sep 14, 2018 in Fresno, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 14, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Fresno, CA (United States)
Additional Details
Clinical BA/BE